Skip to main content
NCBI home page
British Heart Journal logoLink to British Heart Journal
. 1986 Apr;55(4):400–404. doi: 10.1136/hrt.55.4.400

Echocardiographic evaluation of verapamil in Friedreich's ataxia.

F Casazza, F Ferrari, G Finocchiaro, J Hartwig, U Piccone, R Tramarin, M Morpurgo
PMCID: PMC1236745  PMID: 3964508

Abstract

Nine patients with hypertrophic cardiomyopathy associated with Friedreich's ataxia were treated with the calcium antagonist verapamil, which is known to reduce myocardial hypertrophy and improve diastolic function in patients with idiopathic hypertrophic cardiomyopathy. Daily oral doses of 7 mg/kg were given for a mean (SD) of 24 (8) months. M mode echocardiography performed at the start of the study and at the end of follow up showed no significant difference between the treated group and an untreated control group of nine patients. Verapamil produced no changes in left ventricular wall thickness, mass index, left ventricular internal diameter, fractional shortening, peak normalised lengthening rate, peak rate of septal and posterior wall thinning, and time from minimum ventricular cavity dimension to mitral valve opening. Myocardial calcium overload has been suggested as a cause of cardiac disease in Friedreich's ataxia; however, verapamil had no beneficial effect on these patients with established myocardial hypertrophy.

Full text

PDF
400

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barbeau A. Friedreich's ataxia 1979: an overview. Can J Neurol Sci. 1979 May;6(2):311–319. doi: 10.1017/s0317167100119821. [DOI] [PubMed] [Google Scholar]
  2. Beulcke G., Bottoni R., Casazza F., Uzziel G., Morpurgo M. Aspects cardiologiques de l'hérédoataxie du type Friedreich. Arch Mal Coeur Vaiss. 1982 May;75(5):583–592. [PubMed] [Google Scholar]
  3. Bonow R. O., Frederick T. M., Bacharach S. L., Green M. V., Goose P. W., Maron B. J., Rosing D. R. Atrial systole and left ventricular filling in hypertrophic cardiomyopathy: effect of verapamil. Am J Cardiol. 1983 May 1;51(8):1386–1391. doi: 10.1016/0002-9149(83)90317-x. [DOI] [PubMed] [Google Scholar]
  4. Bonow R. O., Rosing D. R., Bacharach S. L., Green M. V., Kent K. M., Lipson L. C., Maron B. J., Leon M. B., Epstein S. E. Effects of verapamil on left ventricular systolic function and diastolic filling in patients with hypertrophic cardiomyopathy. Circulation. 1981 Oct;64(4):787–796. doi: 10.1161/01.cir.64.4.787. [DOI] [PubMed] [Google Scholar]
  5. Devereux R. B., Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation. 1977 Apr;55(4):613–618. doi: 10.1161/01.cir.55.4.613. [DOI] [PubMed] [Google Scholar]
  6. Gamble W. H., Shaver J. A., Alvares R. F., Salerni R., Reddy P. S. A critical appraisal of diastolic time intervals as a measure of relaxation in left ventricular hypertrophy. Circulation. 1983 Jul;68(1):76–87. doi: 10.1161/01.cir.68.1.76. [DOI] [PubMed] [Google Scholar]
  7. Geoffroy G., Barbeau A., Breton G., Lemieux B., Aube M., Leger C., Bouchard J. P. Clinical description and roentgenologic evaluation of patients with Friedreich's ataxia. Can J Neurol Sci. 1976 Nov;3(4):279–286. doi: 10.1017/s0317167100025464. [DOI] [PubMed] [Google Scholar]
  8. Gottdiener J. S., Hawley R. J., Maron B. J., Bertorini T. F., Engle W. K. Characteristics of the cardiac hypertrophy in Friedreich's ataxia. Am Heart J. 1982 Apr;103(4 Pt 1):525–531. doi: 10.1016/0002-8703(82)90340-4. [DOI] [PubMed] [Google Scholar]
  9. Hanrath P., Mathey D. G., Kremer P., Sonntag F., Bleifeld W. Effect of verapamil on left ventricular isovolumic relaxation time and regional left ventricular filling in hypertrophic cardiomyopathy. Am J Cardiol. 1980 Jun;45(6):1258–1264. doi: 10.1016/0002-9149(80)90487-7. [DOI] [PubMed] [Google Scholar]
  10. Hewer R. The heart in Friedreich's ataxia. Br Heart J. 1969 Jan;31(1):5–14. doi: 10.1136/hrt.31.1.5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Huxtable R. J. Cardiac pharmacology and cardiomyopathy in Friedreich's ataxia. Can J Neurol Sci. 1978 Feb;5(1):83–91. [PubMed] [Google Scholar]
  12. Kaltenbach M., Hopf R., Kober G., Bussmann W. D., Keller M., Petersen Y. Treatment of hypertrophic obstructive cardiomyopathy with verapamil. Br Heart J. 1979 Jul;42(1):35–42. doi: 10.1136/hrt.42.1.35. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Lamarche J. B., Côté M., Lemieux B. The cardiomyopathy of Friedreich's ataxia morphological observations in 3 cases. Can J Neurol Sci. 1980 Nov;7(4):389–396. doi: 10.1017/s0317167100022927. [DOI] [PubMed] [Google Scholar]
  14. Pasternac A., Król R., Petitclerc R., Harvey C., Andermann E., Barbeau A. Hypertrophic cardiomyopathy in Friedreich's ataxia: symmetric or asymmetric? Can J Neurol Sci. 1980 Nov;7(4):379–382. doi: 10.1017/s0317167100022903. [DOI] [PubMed] [Google Scholar]
  15. Sanchez-Casis G., Cote M., Barbeau A. Pathology of the heart in Friedreich's ataxia: review of the literature and report of one case. Can J Neurol Sci. 1976 Nov;3(4):349–354. doi: 10.1017/s0317167100025580. [DOI] [PubMed] [Google Scholar]
  16. Spicer R. L., Rocchini A. P., Crowley D. C., Rosenthal A. Chronic verapamil therapy in pediatric and young adult patients with hypertrophic cardiomyopathy. Am J Cardiol. 1984 Jun 1;53(11):1614–1619. doi: 10.1016/0002-9149(84)90589-7. [DOI] [PubMed] [Google Scholar]
  17. Sutton M. G., Olukotun A. Y., Tajik A. J., Lovett J. L., Giuliani E. R. Left ventricular function in Friedreich's ataxia. An echocardiographic study. Br Heart J. 1980 Sep;44(3):309–316. doi: 10.1136/hrt.44.3.309. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sutton M. G., Tajik A. J., Gibson D. G., Brown D. J., Seward J. B., Guiliani E. R. Echocardiographic assessment of left ventricular filling and septal and posterior wall dynamics in idiopathic hypertrophic subaortic stenosis. Circulation. 1978 Mar;57(3):512–520. doi: 10.1161/01.cir.57.3.512. [DOI] [PubMed] [Google Scholar]
  19. Tainturier C., Komajda M., Nenna A., Grosgogeat Y., Busquet M., Evans J. Les atteintes cardiaques des maladies de Friedreich: intérêt des investigations cardiologiques non sanglantes. A propos de 13 cas. Rev Med Interne. 1983 Mar;4(1):73–81. doi: 10.1016/s0248-8663(83)80046-0. [DOI] [PubMed] [Google Scholar]
  20. TenCate F. J., Serruys P. W., Mey S., Roelandt J. Effects of short-term administration of verapamil on left ventricular relaxation and filling dynamics measured by a combined hemodynamic-ultrasonic technique in patients with hypertrophic cardiomyopathy. Circulation. 1983 Dec;68(6):1274–1279. doi: 10.1161/01.cir.68.6.1274. [DOI] [PubMed] [Google Scholar]

Articles from British Heart Journal are provided here courtesy of BMJ Publishing Group

RESOURCES